Archive for the ‘Individual Therapy’ Category

Antidepressants

Thursday, February 11th, 2010

Antidepressants are psychiatric medicines used to alleviate mood disorders. Antidepressants work on the brain in a variety of ways, different antidepressants target different areas of the brain  Tricyclic antidepressants were one of the first major antidepressants introduced in the late 1950’s, and were later replaced by selective serotonin reuptake inhitors, or SSRIs. SSRIs  increase the amount of serotonin available to bind to brain’s receptors; Prozac, Zolof, and Paxil are some of today’s most popular SSRI antidepressant drugs.  SNRIs, serotonin-norepinephrine reuptake inhibitors, such as Effexor and Wellbutrin, work by increasing the levels of the neurotransmitters serotonin and norepinephrine in the brain, which plays a role in one’s mood.  

Lately there has been controversy surrounding the overall success of antidepressants. Some researchers argue that people are being too over-medicated,  that antidepressants are not extremely beneficial in patients with mild depression. The placebo effect refers to a patient taking  a sugar pill and reporting  feeling better, simply because they took a pill they were told would improve their condition. In reality, the patient ingested a sugar pill and it was their change in thought that led their condition to improve.

Patient volunteers are told they will receive either the drug or a placebo, and neither the scientist nor the patient knows who is getting the sugar pill as opposed to the actual drug. Most volunteers want to get the actual drug, and several weeks into the clinical trial users know they are on the real drug when they experience side effects.  Some studies have shown that the worse the side effects, the more effective the patient believes the drug is, heightening expectations.

Newsweek argues that the belief in the power of a medical treatment can be self fulfilling, aka the placebo effect.

However, drug advocates argue that the FDA would not have approved ineffective drugs for millions of people to take. The FDA requires two clinical trials to prove that a drug is more effective than the placebo. In patient-doctor relationships, doctors personally monitor and see the positive effect antidepressants have on a patient’s mental state.

In an analysis of six experiments where depressed patients received a placebo or active drug, the true drug effect (the drug’s effect in addition to the placebo effect) was found to be “nonexistent to negligible” in patients with mild and moderate depression.  In patients with very severe symptoms, there was a statistically significant drug benefit.

Certainly, antidepressants have helped tens of millions of people, and people on antidepressants should not discontinue taking their medication. However, antidepressants may not be the best first choice for patients with mild depression.

Psychotherapy has shown to be extremely effective in treating patients with depression, depression ranging from mild to moderate to severe. For some patients, psychotherapy in addition to antidepressant medication works even better. Each individual experiences depression differently, and psychotherapy is particularly tailored to each person’s individual issues.

In the U.S., many patients with depression are treated by their primary care physicians, not psychiatrists.  If you are experiencing depression or any other mental problem, it is important to see a therapist or psychiatrist over a primary care physician. Therapists are able to truly individualize your treatment, and give your mental health the utmost attention.  Apex Behavioral Health can provide you with psychotherapy and psychiatry. Apex is specialized in mental health, all of our staff is certified and qualified. Please don’t hesitate to seek out a doctor or therapist - depression symptoms can get better.

The Newsweek article can be found here: http://www.newsweek.com/id/232781/page/1

The Effects of Cognitve Behavioral Individual Therapy on Anxiety, Depression, & Cancer Coping Skills in Women Initially Diagnosed w/ Cancer

Thursday, February 4th, 2010

Written by: Huda Zenati, Ph.D., LMSW in August 2009, as advised by Dr. Arnold B. Coven, a counseling major in the Doctor of Philosophy.

Abstract

Cancer patients undergo an enormous amount of psychological stress that begins at the diagnosis and continues during treatment, or even until remission. The stress, anxiety, and depression levels are especially high during diagnosis and the following one-year period.

Cognitive behavior therapy has been shown to be effective in decreasing the severity of anxiety in patients who suffer from anxiety disorders, leading to long-term benefits such as better coping skills.  

Procedures

The pupose of this study was to examine the effects of cognitive behavioral short-term individual therapy in women newly diagnosed with various cancers.  Ten women with various types of cancers were referred from physicials who practiced in a large metropolitan area. Each woman who  qualified for the criteria of the study was randomly assigned to the experimental or wait-list control group. The experimental group was treated with cognitive behavior therapy time-limited individual therapy sessions while the wait-list control group underwent no treatment. The criterion instruemtns were the Hospital Anxiety and Depression scale (HAD, Zigmon& Snaith, 1983) and Cancer Coping Questionnaire (CCQ, Moorey, Frampton & Greer, 2003).

After completing two sessions, the five participants in the experimental group received two follow-up phone calls which encouraged participants to use the coping strategies. After the third intervention sessions, the criterion instruments were re-administed to the experimental group to detrmine the treatment effects on the dependant variables, anxiety, depression, and coping strategies.

The five participants assigned to the wait-list control group did not recieve any treatment.  The researcher met with each participant assigned to the wait-list congrol group to obtain the signed informed consent form, demographic form, and criterion instruments. The instruments were re-administered at the end of the 4th week by telephone, in person, or return mail.

Results

The statistical power consideration based on the sample size limitation  (n=5 per group) required implementing nonparametric exact tests (Mann-Whitney U and Wilcoxon W tests) rather than asymptotic parametric tests. The findings supported all three research hypotheses. A statistically significant decrease in anxiety and depression symptoms, along with an increase in cancer coping skills, were found in women initially diagnosed  with cancer receiving treatment when compared to the participants who received no treatment.

Switch to our mobile site